Skip to main content
. 2020 Jun 12;85:104419. doi: 10.1016/j.meegid.2020.104419

Fig. S7.

Fig. S7

Interaction models of different drugs and SARS-CoV-2 S protein. The interaction between different drugs and SARS-CoV-2 S protein were virtualized to calculate binding affinity. The structure and interacting spots of each drug are shown. (A) Bictegravir (DB11799, PubChem CID: 129626368); (B) Temsirolimus (DB06287, PubChem CID: 134812825); (C) Dolutegravi (DB08930, PubChem CID: 54726191); (D) Elbasvir (DB11574, PubChem CID: 71661251); (E) Irbesartan (DB01029, PubChem CID: 3749); (F) Gliquidone (DB01251, PubChem CID: 91610); (G) Lanreotide (DB06791, PubChem CID: 71349); (H) Tasosartan (DB01349, PubChem CID: 60919); (I) Velpatasvir (DB11613, PubChem CID: 67683363).